Elon Musk’s Neuralink brain computer startup is beat again. This time a competitor implanted its device into its first U.S. patient

Elon Musk’s Neuralink brain computing startup has yet to receive approval from the Federal Drug Administration to implant its technology in humans. However, Neuralink’s competitor, Synchron, has implanted its first device into the brain of a U.S. patient — in this case one with ALS, a neurodegenerative disease that’s affected the patient’s ability to move and speak, as reported by Bloomberg.

The hope is that the patient will be able to browse the web and communicate through email and text just by thinking. The device would translate the patient’s thoughts into action through commands sent to a computer.

Synchron had already implanted its devices in four patients in Australia. These patients are reported by Bloomberg to have no side effects, and the device has allowed them to send messages through WhatsApp and make online purchases.   Source: Fortune


Fair Use Notice:This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond 'fair use', you must obtain permission from the copyright owner.

Leave a Comment